Summary Dashboard

Explore, analyze, and download tuberculosis (TB) data from USAID's TB priority countries to inform efforts to maximize investments and move toward eliminating the disease.

How to use the charts: Roll over the data value to view the description. Click on and off of the key below each graph to make the values appear and disappear. Use the menu to print, download as an image, PDF, or CSV, or view the data table.

Explore the data by objective:

This chart denotes TB case notification and treatment success rates for each of USAID’s priority countries in 2016.

REACH

This chart shows aggregate TB case notifications in USAID priority countries from the initiation of the USAID TB program in 2000 through 2017, and the United Nations High Level Meeting (UN HLM) notification targets for 2018 to 2022.

This chart demonstrates trends in TB treatment coverage for all forms of TB in USAID countries between 2013 and 2017.

This chart illustrates the number of drug-resistant (DR) TB cases in USAID priority countries, including rifampicin-resistant (RR), multidrug-resistant (MDR), and extensively drug-resistant (XDR) cases, notified between 2011 and 2017. In 2017, notified cases represented 26% of estimated DR-TB cases in USAID priority countries.

This chart demonstrates DR-TB treatment coverage for USAID countries in 2017.

The chart above shows the percent of new and relapse TB cases in USAID priority countries whose HIV status was documented. In 2017, only 10% of TB cases worldwide were co-infected with HIV. However, TB/HIV co-infection rates vary dramatically by region, as demonstrated in the pie chart below, showing the relative distribution of TB/HIV co-infected among notified TB cases in USAID priority countries.

CURE

This chart indicates the annual number of TB patients who successfully completed treatment in USAID priority countries between 2012 and 2016, documented by bacteriologic methods or completion of therapy.

This chart illustrates the percent of new and relapse cases (2016 cohort) that were successfully treated in each of USAID’s priority countries.

This chart presents the trend in the number of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB cases in USAID priority countries who have successfully completed treatment between 2007 and 2015.

This chart indicates the percent of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB cases successfully treated in USAID priority countries in 2015.

PREVENT

This chart shows the number of people living with HIV (PLHIV) in USAID priority countries who were initiated on TB preventive treatment (TPT) between 2002 and 2017, and the United Nations High Level Meeting (UN HLM) PLHIV TPT targets for 2018 to 2022.

This chart illustrates the percent of people living with HIV (PLHIV) newly enrolled in clinical care in USAID priority countries, who initiated TB preventive treatment (TPT) in 2014.

This chart shows the percent of children under 5 who were household contacts of bacteriologically-confirmed TB cases and initiated on TB preventive treatment (TPT) in each of USAID's priority countries in 2017.

*Both Afghanistan and Mozambique have percentages beyond 100% because the number of children initiating TPT is greater than the estimated number of eligible children.

About the Data

The data used to generate the dashboards was obtained through the World Health Organization’s public website. The data includes the WHO TB burden estimates and data organized by countries, regions, and themes. These graphic representations are subject to change over time as data is updated.

For questions and comments pertaining to the hub and source data, please email: hub@tbdiah.org.